NF-kappa	B-protein
B	I-protein
-dependent	O
induction	O
of	O
the	O
NF-kappa	B-protein
B	I-protein
p50	B-DNA
subunit	I-DNA
gene	I-DNA
promoter	I-DNA
underlies	O
self-perpetuation	O
of	O
human	O
immunodeficiency	O
virus	O
transcription	O
in	O
monocytic	B-cell_type
cells	I-cell_type
.	O

The	O
molecular	O
mechanisms	O
underlying	O
the	O
sustained	O
nuclear	O
translocation	O
of	O
NF-kappa	B-protein
B	I-protein
observed	O
in	O
U937	B-cell_line
monocytic	I-cell_line
cells	I-cell_line
chronically	O
infected	O
with	O
human	O
immunodeficiency	O
virus	O
(	O
HIV	O
)	O
were	O
studied	O
.	O

The	O
activity	O
of	O
the	O
promoter	B-DNA
regulating	O
the	O
synthesis	O
of	O
the	O
p105	B-protein
precursor	I-protein
of	O
the	O
NF-kappa	B-protein
B	I-protein
p50	I-protein
subunit	I-protein
was	O
enhanced	O
in	O
these	O
cells	O
.	O

Deletions	O
in	O
this	O
promoter	B-DNA
indicated	O
that	O
this	O
upregulation	O
was	O
mediated	O
through	O
the	O
NF-kappa	O
B-	O
but	O
not	O
the	O
AP-1-binding	B-DNA
motif	I-DNA
,	O
by	O
bona	O
fide	O
p50/p65	B-protein
heterodimers	I-protein
.	O

Analysis	O
of	O
cytosolic	O
extracts	O
indicated	O
that	O
NF-kappa	B-protein
B	I-protein
levels	O
were	O
increased	O
in	O
HIV-infected	B-cell_type
cells	I-cell_type
.	O

In	O
contrast	O
to	O
the	O
transient	O
NF-kappa	B-protein
B	I-protein
activation	O
induced	O
by	O
phorbol	O
ester	O
,	O
the	O
permanent	O
NF-kappa	B-protein
B	I-protein
translocation	O
induced	O
by	O
HIV	O
infection	O
was	O
not	O
dependent	O
on	O
PKC	B-protein
isoenzymes	I-protein
alpha	I-protein
and	I-protein
beta	I-protein
as	O
shown	O
by	O
the	O
use	O
of	O
a	O
specific	O
inhibitor	O
(	O
GF	O
109203X	O
)	O
.	O

These	O
observations	O
indicate	O
that	O
during	O
chronic	O
HIV	O
infection	O
of	O
U937	B-cell_line
cells	I-cell_line
,	O
continuous	O
NF-kappa	B-protein
B	I-protein
(	O
p50/p65	B-protein
)	O
translocation	O
results	O
in	O
p105	O
promoter	O
upregulation	O
with	O
subsequent	O
cytosolic	O
NF-kappa	B-protein
B	I-protein
accumulation	O
,	O
ready	O
for	O
further	O
translocation	O
.	O

This	O
HIV-mediated	O
mechanism	O
results	O
in	O
a	O
self-perpetuating	O
loop	O
of	O
NF-kappa	B-protein
B	I-protein
production	O
.	O

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
Vol	NULL
.	NULL

89	NULL
,	NULL
pp	NULL
.	NULL

7826-7830	NULL
,	NULL
August	NULL
1992	NULL
Medical	NULL
Sciences	NULL
NF-	NULL
«	NULL
B-dependent	NULL
induction	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
subunit	NULL
gene	NULL
promoter	NULL
underlies	NULL
self-perpetuation	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
transcription	NULL
in	NULL
monocytic	NULL
cells	NULL
CARLOS	NULL
V	NULL
.	NULL

Paya*	NULL
?	NULL
}	NULL

,	NULL
Rosa	NULL
M.	NULL
Tent§	NULL
,	NULL
Curistin®E	NULL
Bessta*	NULL
,	NULL
JosE	NULL
ArcamMI*1	NULL
,	NULL
RonaLp	NULL
T	NULL
.	NULL

Hay	NULL
!	NULL

!	NULL

,	NULL
AND	NULL
JEAN-LOUIS	NULL
VIRELIZIER*	NULL
*Unite	NULL
d'Immunologie	NULL
Virale	NULL
and	NULL
5Unite	NULL
de	NULL
Biologie	NULL
Moleculaire	NULL
du	NULL
Gene	NULL
,	NULL
Institut	NULL
Pasteur	NULL
,	NULL
75724	NULL
Paris	NULL
,	NULL
France	NULL
;	NULL
and	NULL
``	NULL
Department	NULL
of	NULL
Biochemistry	NULL
and	NULL
Microbiology	NULL
,	NULL
University	NULL
of	NULL
St.	NULL
Andrews	NULL
,	NULL
St.	NULL
Andrews	NULL
,	NULL
Fife	NULL
,	NULL
KY16	NULL
IAL	NULL
,	NULL
Scotland	NULL
,	NULL
United	NULL
Kingdom	NULL
Communicated	NULL
by	NULL
Francois	NULL
Jacob	NULL
,	NULL
May	NULL
20	NULL
,	NULL
1992	NULL
ABSTRACT	NULL
The	NULL
molecular	NULL
mechanisms	NULL
underlying	NULL
the	NULL
sustained	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-xB	NULL
observed	NULL
in	NULL
U937	NULL
monocytic	NULL
cells	NULL
chronically	NULL
infected	NULL
with	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV	NULL
)	NULL
were	NULL
studied	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
the	NULL
promoter	NULL
regulating	NULL
the	NULL
synthesis	NULL
of	NULL
the	NULL
p105	NULL
precursor	NULL
of	NULL
the	NULL
NF-B	NULL
p50	NULL
subunit	NULL
was	NULL
enhanced	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Deletions	NULL
in	NULL
this	NULL
promoter	NULL
indicated	NULL
that	NULL
this	NULL
upregulation	NULL
was	NULL
mediated	NULL
through	NULL
the	NULL
NF-B-	NULL
but	NULL
not	NULL
the	NULL
AP-1-binding	NULL
motif	NULL
,	NULL
by	NULL
bona	NULL
fide	NULL
p50/p6S	NULL
heterodimers	NULL
.	NULL

Analysis	NULL
of	NULL
cytosolic	NULL
extracts	NULL
indicated	NULL
that	NULL
NF-KB	NULL
levels	NULL
were	NULL
increased	NULL
in	NULL
HIV-infected	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
transient	NULL
NF-xB	NULL
activation	NULL
induced	NULL
by	NULL
phorbol	NULL
ester	NULL
,	NULL
the	NULL
permanent	NULL
NF-B	NULL
translocation	NULL
induced	NULL
by	NULL
HIV	NULL
infection	NULL
was	NULL
not	NULL
dependent	NULL
on	NULL
PKC	NULL
isoenzymes	NULL
a	NULL
and	NULL
#	NULL
as	NULL
shown	NULL
by	NULL
the	NULL
use	NULL
of	NULL
a	NULL
specific	NULL
inhibitor	NULL
(	NULL
GF	NULL
109203	NULL
%	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
indicate	NULL
that	NULL
during	NULL
chronic	NULL
HIV	NULL
infection	NULL
of	NULL
U937	NULL
cells	NULL
,	NULL
continuous	NULL
NF-xB	NULL
(	NULL
p50	NULL
translocation	NULL
results	NULL
in	NULL
p105	NULL
promoter	NULL
upregulation	NULL
with	NULL
subsequent	NULL
cytosolic	NULL
NF-xB	NULL
accumulation	NULL
,	NULL
ready	NULL
for	NULL
further	NULL
translocation	NULL
.	NULL

This	NULL
HIV-mediated	NULL
mechanism	NULL
results	NULL
in	NULL
a	NULL
self-perpetuating	NULL
loop	NULL
of	NULL
NF-xB	NULL
production	NULL
.	NULL

A	NULL
major	NULL
mechanism	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV	NULL
)	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
transactivation	NULL
resulting	NULL
in	NULL
viral	NULL
transcription	NULL
is	NULL
mediated	NULL
by	NULL
nuclear	NULL
factor	NULL
«	NULL
kB	NULL
(	NULL
NF-	NULL
«	NULL
B	NULL
)	NULL
,	NULL
which	NULL
binds	NULL
to	NULL
the	NULL
two	NULL
«	NULL
B	NULL
motifs	NULL
constituting	NULL
the	NULL
LTR	NULL
enhancer	NULL
region	NULL
(	NULL
1	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
is	NULL
a	NULL
heterodimer	NULL
composed	NULL
of	NULL
50-kDa	NULL
(	NULL
p50	NULL
)	NULL
and	NULL
65-kDa	NULL
(	NULL
p65	NULL
)	NULL
subunits	NULL
(	NULL
2-4	NULL
)	NULL
,	NULL
for	NULL
which	NULL
cDNAs	NULL
have	NULL
been	NULL
cloned	NULL
(	NULL
5-9	NULL
)	NULL
.	NULL

In	NULL
the	NULL
majority	NULL
of	NULL
cells	NULL
studied	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
present	NULL
in	NULL
an	NULL
inactive	NULL
form	NULL
in	NULL
the	NULL
cyto-plasm	NULL
,	NULL
bound	NULL
through	NULL
the	NULL
p65	NULL
subunit	NULL
to	NULL
the	NULL
inhibitory	NULL
protein	NULL
IkB	NULL
(	NULL
3	NULL
,	NULL
4	NULL
,	NULL
8	NULL
,	NULL
10-12	NULL
)	NULL
and	NULL
its	NULL
phosphorylation	NULL
by	NULL
kinases	NULL
prevents	NULL
this	NULL
inhibitory	NULL
binding	NULL
,	NULL
allowing	NULL
NF-KB	NULL
to	NULL
translocate	NULL
to	NULL
the	NULL
nucleus	NULL
(	NULL
13	NULL
,	NULL
14	NULL
)	NULL
.	NULL

The	NULL
deduced	NULL
amino	NULL
acid	NULL
sequences	NULL
of	NULL
the	NULL
p50	NULL
and	NULL
p65	NULL
subunits	NULL
show	NULL
that	NULL
they	NULL
belong	NULL
to	NULL
the	NULL
same	NULL
multigene	NULL
family	NULL
as	NULL
the	NULL
c-re/	NULL
protooncogene	NULL
product	NULL
(	NULL
5	NULL
,	NULL
6	NULL
,	NULL
8	NULL
,	NULL
9	NULL
)	NULL
.	NULL

Members	NULL
of	NULL
this	NULL
family	NULL
associate	NULL
into	NULL
multiple	NULL
homo-	NULL
or	NULL
heterodimeric	NULL
forms	NULL
that	NULL
can	NULL
bind	NULL
specific	NULL
decameric	NULL
DNA	NULL
sequences	NULL
(	NULL
«	NULL
xB	NULL
motifs	NULL
)	NULL
in	NULL
the	NULL
regulatory	NULL
region	NULL
of	NULL
multiple	NULL
genes	NULL
.	NULL

The	NULL
functional	NULL
activity	NULL
of	NULL
a	NULL
xB	NULL
motif	NULL
may	NULL
depend	NULL
on	NULL
both	NULL
the	NULL
exact	NULL
sequence	NULL
of	NULL
the	NULL
motif	NULL
and	NULL
the	NULL
protein	NULL
subunits	NULL
involved	NULL
(	NULL
2-4	NULL
,	NULL
15-19	NULL
)	NULL
.	NULL

Chronic	NULL
HIV	NULL
infection	NULL
of	NULL
the	NULL
monocytic	NULL
cell	NULL
line	NULL
U937	NULL
induces	NULL
nuclear	NULL
translocation	NULL
of	NULL
an	NULL
HIV	NULL
enhancer-binding	NULL
protein	NULL
complex	NULL
with	NULL
functional	NULL
properties	NULL
compatible	NULL
with	NULL
that	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
20	NULL
)	NULL
,	NULL
thus	NULL
adding	NULL
HIV	NULL
infection	NULL
itself	NULL
to	NULL
the	NULL
list	NULL
of	NULL
events	NULL
that	NULL
can	NULL
induce	NULL
HIV	NULL
LTR	NULL
transactivation	NULL
,	NULL
implying	NULL
that	NULL
HIV	NULL
genome	NULL
transcription	NULL
may	NULL
be	NULL
self-perpetuated	NULL
in	NULL
monocytes	NULL
.	NULL

The	NULL
present	NULL
investigation	NULL
was	NULL
aimed	NULL
at	NULL
deter-mining	NULL
,	NULL
at	NULL
the	NULL
molecular	NULL
level	NULL
,	NULL
how	NULL
U937	NULL
cells	NULL
sustain	NULL
such	NULL
an	NULL
intense	NULL
and	NULL
persistent	NULL
NF-	NULL
«	NULL
B	NULL
translocation	NULL
as	NULL
a	NULL
result	NULL
of	NULL
The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

§1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

7826	NULL
chronic	NULL
HIV	NULL
replication	NULL
.	NULL

For	NULL
this	NULL
to	NULL
occur	NULL
,	NULL
some	NULL
mechanism	NULL
of	NULL
permanent	NULL
refeeding	NULL
of	NULL
the	NULL
translocable	NULL
cytoplasmic	NULL
pool	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
must	NULL
be	NULL
postulated	NULL
.	NULL

Maintenance	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
continuous	NULL
presence	NULL
of	NULL
stimuli	NULL
such	NULL
as	NULL
tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
TNF	NULL
)	NULL
or	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
(	NULL
PMA	NULL
)	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Further	NULL
,	NULL
these	NULL
stimuli	NULL
can	NULL
increase	NULL
the	NULL
level	NULL
of	NULL
mRNA	NULL
encoding	NULL
the	NULL
p105	NULL
precursor	NULL
of	NULL
the	NULL
p50	NULL
subunit	NULL
,	NULL
suggesting	NULL
that	NULL
regulation	NULL
of	NULL
the	NULL
p105	NULL
gene	NULL
is	NULL
NF-	NULL
«	NULL
B-dependent	NULL
(	NULL
7	NULL
,	NULL
22	NULL
)	NULL
.	NULL

Cloning	NULL
and	NULL
functional	NULL
analysis	NULL
of	NULL
the	NULL
cellular	NULL
promoter	NULL
regulating	NULL
the	NULL
p105	NULL
gene	NULL
showed	NULL
that	NULL
it	NULL
contained	NULL
binding	NULL
motifs	NULL
for	NULL
the	NULL
transcription	NULL
factors	NULL
AP-1	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
23	NULL
)	NULL
.	NULL

We	NULL
have	NULL
now	NULL
tested	NULL
the	NULL
hypothesis	NULL
that	NULL
during	NULL
chronic	NULL
HIV	NULL
infection	NULL
,	NULL
continuous	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
leads	NULL
to	NULL
permanent	NULL
upregulation	NULL
of	NULL
p105	NULL
gene	NULL
transcription	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
results	NULL
in	NULL
cytoplasmic	NULL
accumulation	NULL
of	NULL
the	NULL
p50	NULL
protein	NULL
in	NULL
association	NULL
with	NULL
p65	NULL
and	NULL
IxB	NULL
,	NULL
as	NULL
a	NULL
complex	NULL
ready	NULL
for	NULL
further	NULL
nuclear	NULL
translocation	NULL
.	NULL

Predictions	NULL
from	NULL
this	NULL
hypothesis	NULL
would	NULL
be	NULL
that	NULL
(	NULL
i	NULL
)	NULL
bona	NULL
fide	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
p50/p65	NULL
heterodimer	NULL
)	NULL
is	NULL
translocated	NULL
into	NULL
the	NULL
nucleus	NULL
of	NULL
HIV-infected	NULL
cells	NULL
from	NULL
a	NULL
permanently	NULL
increased	NULL
pool	NULL
of	NULL
cytoplasmic	NULL
NF-	NULL
«	NULL
B	NULL
;	NULL
(	NULL
ii	NULL
)	NULL
activity	NULL
of	NULL
the	NULL
p105	NULL
promoter	NULL
is	NULL
constitutively	NULL
enhanced	NULL
in	NULL
HIV-infected	NULL
cells	NULL
,	NULL
through	NULL
the	NULL
NF-	NULL
«	NULL
B-	NULL
and	NULL
not	NULL
the	NULL
AP-1-binding	NULL
DNA	NULL
motif	NULL
,	NULL
and	NULL
that	NULL
it	NULL
is	NULL
not	NULL
mediated	NULL
by	NULL
the	NULL
HIV	NULL
Tat	NULL
protein	NULL
;	NULL
and	NULL
(	NULL
#	NULL
i	NULL
?	NULL
)	NULL

intracellular	NULL
signaling	NULL
transduction	NULL
pathways	NULL
leading	NULL
to	NULL
persistent	NULL
NF-	NULL
«	NULL
B	NULL
translocation	NULL
are	NULL
different	NULL
from	NULL
those	NULL
used	NULL
by	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
PKC	NULL
)	NULL
-activating	NULL
stimuli	NULL
such	NULL
as	NULL
PMA	NULL
,	NULL
which	NULL
are	NULL
known	NULL
to	NULL
induce	NULL
a	NULL
brisk	NULL
,	NULL
but	NULL
not	NULL
sustained	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
translocation	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Our	NULL
observations	NULL
in	NULL
chronically	NULL
HIV-infected	NULL
U937	NULL
cells	NULL
show	NULL
that	NULL
these	NULL
requirements	NULL
are	NULL
met	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Reagents	NULL
,	NULL
Antibodies	NULL
,	NULL
and	NULL
Cells	NULL
.	NULL

PKC	NULL
inhibitor	NULL
GF	NULL
109203X	NULL
(	NULL
24	NULL
)	NULL
was	NULL
provided	NULL
by	NULL
J.	NULL
Kirilovsky	NULL
(	NULL
Glaxo	NULL
)	NULL
.	NULL

Antisera	NULL
to	NULL
p50	NULL
(	NULL
5	NULL
)	NULL
and	NULL
against	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
c-Rel	NULL
(	NULL
18	NULL
)	NULL
were	NULL
kindly	NULL
donated	NULL
by	NULL
A.	NULL
Israel	NULL
(	NULL
Institut	NULL
Pasteur	NULL
,	NULL
Paris	NULL
)	NULL
and	NULL
I.	NULL
Verma	NULL
(	NULL
Salk	NULL
Institute	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

U937	NULL
cells	NULL
routinely	NULL
used	NULL
in	NULL
our	NULL
laboratory	NULL
have	NULL
been	NULL
described	NULL
(	NULL
20	NULL
)	NULL
.	NULL

K562	NULL
human	NULL
erythro-leukemia	NULL
cells	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
ATCC	NULL
.	NULL

Cells	NULL
were	NULL
periodically	NULL
tested	NULL
for	NULL
mycoplasma	NULL
and	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
with	NULL
glutamine	NULL
,	NULL
antibiotics	NULL
,	NULL
and	NULL
5	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
.	NULL

They	NULL
were	NULL
passed	NULL
twice	NULL
a	NULL
week	NULL
and	NULL
seeded	NULL
at	NULL
2.5	NULL
x	NULL
10°	NULL
cells	NULL
per	NULL
ml	NULL
,	NULL
at	NULL
<	NULL
3	NULL
X	NULL
10	NULL
``	NULL
cells	NULL
per	NULL
150-cm	NULL
>	NULL
flask	NULL
.	NULL

Abbreviations	NULL
:	NULL
HIV	NULL
,	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
;	NULL
LTR	NULL
,	NULL
long	NULL
terminal	NULL
repeat	NULL
;	NULL
PKC	NULL
,	NULL
protein	NULL
kinase	NULL
C	NULL
;	NULL
PMA	NULL
,	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
;	NULL
TNF	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
;	NULL
rlu	NULL
,	NULL
relative	NULL
light	NULL
units	NULL
.	NULL

*Present	NULL
address	NULL
:	NULL
Division	NULL
of	NULL
Infectious	NULL
Diseases	NULL
,	NULL
Mayo	NULL
Clinic	NULL
,	NULL
200	NULL
1st	NULL
Street	NULL
,	NULL
S.W	NULL
.	NULL

,	NULL
Rochester	NULL
,	NULL
MN	NULL
55905	NULL
.	NULL

*To	NULL
whom	NULL
reprint	NULL
requests	NULL
should	NULL
be	NULL
sent	NULL
at	NULL
the	NULL
t	NULL
address	NULL
.	NULL

Present	NULL
address	NULL
:	NULL
Centro	NULL
de	NULL
Investigacion	NULL
,	NULL
Hospital	NULL
12	NULL
de	NULL
Octubre	NULL
,	NULL
28041	NULL
Madrid	NULL
,	NULL
Spain	NULL
.	NULL

Medical	NULL
Sciences	NULL
:	NULL
Paya	NULL
et	NULL
al	NULL
.	NULL

Expression	NULL
and	NULL
Purification	NULL
of	NULL
p50	NULL
and	NULL
IxB	NULL
.	NULL

DNA	NULL
coding	NULL
for	NULL
the	NULL
DNA-binding	NULL
domain	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p105	NULL
(	NULL
amino	NULL
acids	NULL
38-381	NULL
)	NULL
in	NULL
the	NULL
sequence	NULL
of	NULL
KBF1	NULL
(	NULL
5	NULL
)	NULL
was	NULL
isolated	NULL
by	NULL
PCR	NULL
and	NULL
inserted	NULL
into	NULL
the	NULL
pGEX-2T	NULL
expression	NULL
plasmid	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Bacte-rially	NULL
expressed	NULL
fusion	NULL
protein	NULL
was	NULL
isolated	NULL
through	NULL
double-stranded	NULL
DNA	NULL
affinity	NULL
chromatography	NULL
on	NULL
glutathione-agarose	NULL
and	NULL
cleaved	NULL
with	NULL
thrombin	NULL
,	NULL
and	NULL
the	NULL
DNA-binding	NULL
domain	NULL
of	NULL
p50	NULL
was	NULL
isolated	NULL
by	NULL
affinity	NULL
chromatography	NULL
.	NULL

To	NULL
isolate	NULL
DNA	NULL
coding	NULL
for	NULL
IxB	NULL
,	NULL
primers	NULL
based	NULL
on	NULL
the	NULL
sequence	NULL
of	NULL
Haskill	NULL
et	NULL
al	NULL
.	NULL

(	NULL
26	NULL
)	NULL
were	NULL
used	NULL
for	NULL
PCR	NULL
amplification	NULL
of	NULL
sequences	NULL
present	NULL
in	NULL
reverse-transcribed	NULL
HeLa	NULL
cell	NULL
mRNA	NULL
,	NULL
which	NULL
were	NULL
then	NULL
inserted	NULL
into	NULL
pGEX-2T	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Expressed	NULL
fusion	NULL
protein	NULL
was	NULL
isolated	NULL
by	NULL
affinity	NULL
chromatography	NULL
on	NULL
glutathione-agarose	NULL
and	NULL
IxB	NULL
was	NULL
released	NULL
by	NULL
thrombin	NULL
treatment	NULL
(	NULL
J.	NULL
R.	NULL
Mathews	NULL
and	NULL
R.T.H	NULL
.	NULL

,	NULL
unpublished	NULL
work	NULL
)	NULL
.	NULL

HIV	NULL
Infection	NULL
of	NULL
U937	NULL
Cells	NULL
.	NULL

Infection	NULL
with	NULL
mycoplasma-negative	NULL
LAV-1	NULL
Bru	NULL
strain	NULL
of	NULL
HIV	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Reverse	NULL
transcriptase	NULL
activity	NULL
in	NULL
the	NULL
supernatant	NULL
of	NULL
uninfected	NULL
and	NULL
infected	NULL
U937	NULL
cells	NULL
was	NULL
tested	NULL
twice	NULL
a	NULL
week	NULL
at	NULL
the	NULL
time	NULL
of	NULL
cell	NULL
passage	NULL
,	NULL
and	NULL
p24	NULL
antigen	NULL
in	NULL
culture	NULL
supernatant	NULL
was	NULL
measured	NULL
every	NULL
other	NULL
cell	NULL
passage	NULL
.	NULL

Over	NULL
80	NULL
%	NULL
of	NULL
the	NULL
infected	NULL
cells	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
produce	NULL
HIV	NULL
gag	NULL
transcripts	NULL
as	NULL
determined	NULL
by	NULL
in	NULL
situ	NULL
hybridization	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
used	NULL
between	NULL
days	NULL
21	NULL
and	NULL
120	NULL
postinfection	NULL
.	NULL

The	NULL
degree	NULL
of	NULL
viral	NULL
replication	NULL
,	NULL
as	NULL
measured	NULL
by	NULL
reverse	NULL
transcriptase	NULL
activity	NULL
and	NULL
p24	NULL
antigen	NULL
,	NULL
was	NULL
essentially	NULL
constant	NULL
during	NULL
this	NULL
time	NULL
period	NULL
.	NULL

Three	NULL
different	NULL
chronic	NULL
HIV	NULL
infections	NULL
of	NULL
U937	NULL
cells	NULL
were	NULL
used	NULL
for	NULL
these	NULL
experiments	NULL
,	NULL
and	NULL
cells	NULL
were	NULL
used	NULL
at	NULL
different	NULL
times	NULL
after	NULL
the	NULL
onset	NULL
of	NULL
infections	NULL
in	NULL
each	NULL
chronically	NULL
infected	NULL
culture	NULL
.	NULL

TNF	NULL
and	NULL
interleukin	NULL
1	NULL
were	NULL
not	NULL
detected	NULL
in	NULL
the	NULL
supernatant	NULL
of	NULL
HIV-infected	NULL
U937	NULL
cells	NULL
as	NULL
measured	NULL
by	NULL
bioassay	NULL
and	NULL
enzyme	NULL
immunoassay	NULL
.	NULL

Gel	NULL
Mobility-Shift	NULL
Assays	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
obtained	NULL
as	NULL
described	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Cells	NULL
(	NULL
5	NULL
x	NULL
10°	NULL
)	NULL
were	NULL
seeded	NULL
at	NULL
2.5	NULL
x	NULL
10°	NULL
per	NULL
ml	NULL
on	NULL
the	NULL
day	NULL
of	NULL
cell	NULL
passage	NULL
and	NULL
harvested	NULL
16	NULL
hr	NULL
later	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
stimuli	NULL
.	NULL

Cytosolic	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
lysing	NULL
the	NULL
cells	NULL
for	NULL
6	NULL
min	NULL
at	NULL
4°C	NULL
with	NULL
10	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
8/10	NULL
mM	NULL
KCI/O0.5	NULL
M	NULL
sucrose/l1	NULL
mM	NULL
EDTA/O.5	NULL
mM	NULL
spermidine/0.15	NULL
mM	NULL
spermine/0.3	NULL
%	NULL
Nonidet	NULL
P-40/7	NULL
mM	NULL
2-mercaptoethanol	NULL
containing	NULL
phenylmethanesulfonyl	NULL
fluoride	NULL
,	NULL
leupeptin	NULL
,	NULL
pepstatin	NULL
,	NULL
and	NULL
aprotinin	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
microcentrifuged	NULL
at	NULL
6500	NULL
rpm	NULL
at	NULL
4°C	NULL
and	NULL
the	NULL
supernatant	NULL
was	NULL
kept	NULL
at	NULL
-80°C	NULL
until	NULL
tested	NULL
.	NULL

Nuclear	NULL
extract	NULL
was	NULL
prepared	NULL
from	NULL
the	NULL
pellet	NULL
.	NULL

For	NULL
mobility-shift	NULL
assays	NULL
,	NULL
5-7	NULL
ug	NULL
of	NULL
protein	NULL
extract	NULL
was	NULL
incubated	NULL
with	NULL
[	NULL
y-	NULL
>	NULL
P	NULL
]	NULL
JATP-labeled	NULL
double-stranded	NULL
synthetic	NULL
oligodeoxynucleotide	NULL
probe	NULL
at	NULL
22°C	NULL
for	NULL
15	NULL
min	NULL
in	NULL
10	NULL
l	NULL
of	NULL
buffer	NULL
as	NULL
described	NULL
(	NULL
20	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
reaction	NULL
was	NULL
analyzed	NULL
by	NULL
electrophoresis	NULL
in	NULL
nondenaturing	NULL
6	NULL
%	NULL
poly-acrylamide	NULL
gels	NULL
.	NULL

DNA-binding	NULL
competition	NULL
was	NULL
assessed	NULL
by	NULL
preincubating	NULL
the	NULL
extract	NULL
with	NULL
a	NULL
40-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotide	NULL
.	NULL

In	NULL
cytosolic	NULL
extract	NULL
,	NULL
sodium	NULL
deoxycholate	NULL
was	NULL
added	NULL
(	NULL
0.8	NULL
%	NULL
,	NULL
wt/vol	NULL
)	NULL
and	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
10	NULL
min	NULL
.	NULL

When	NULL
indicated	NULL
,	NULL
0.5-3	NULL
ul	NULL
of	NULL
rabbit	NULL
antiserum	NULL
or	NULL
15	NULL
ng	NULL
of	NULL
rIxB	NULL
was	NULL
added	NULL
to	NULL
the	NULL
standard	NULL
reaction	NULL
mixture	NULL
10	NULL
min	NULL
before	NULL
addition	NULL
of	NULL
the	NULL
radiolabeled	NULL
probe	NULL
.	NULL

The	NULL
oligonucleotide	NULL
used	NULL
in	NULL
the	NULL
binding	NULL
reactions	NULL
corresponded	NULL
to	NULL
the	NULL
wild-type	NULL
NF-	NULL
«	NULL
B-binding	NULL
sequence	NULL
,	NULL
which	NULL
constitutes	NULL
the	NULL
enhancer	NULL
of	NULL
the	NULL
HIV	NULL
LTR	NULL
(	NULL
§5-ACAAGGGACTTTCCGC-TGGGGACTTTCCAGGGA-3	NULL
'	NULL
)	NULL
.	NULL

The	NULL
double-stranded	NULL
probe	NULL
was	NULL
labeled	NULL
with	NULL
[	NULL
a-	NULL
>	NULL
P	NULL
]	NULL
dCTP	NULL
by	NULL
Klenow	NULL
DNA	NULL
polymerase	NULL
.	NULL

Plasmid	NULL
Constructs	NULL
.	NULL

Plasmid	NULL
p105-luc	NULL
consisted	NULL
of	NULL
a	NULL
1.2-kilobase	NULL
HindlIII-Nco	NULL
I	NULL
fragment	NULL
of	NULL
the	NULL
p105	NULL
genomic	NULL
clone	NULL
,	NULL
cloned	NULL
into	NULL
the	NULL
HindIII	NULL
site	NULL
of	NULL
the	NULL
pc-luc	NULL
plasmid	NULL
,	NULL
upstream	NULL
of	NULL
the	NULL
luciferase	NULL
reporter	NULL
gene	NULL
(	NULL
23	NULL
,	NULL
27	NULL
)	NULL
.	NULL

The	NULL
p105dkB-luc	NULL
and	NULL
pl05dAP1l-luc	NULL
vectors	NULL
represent	NULL
the	NULL
p105-luc	NULL
plasmid	NULL
with	NULL
the	NULL
«	NULL
B	NULL
or	NULL
AP-1	NULL
motif	NULL
deleted	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
HIV	NULL
LTR	NULL
wild-type	NULL
plasmid	NULL
contained	NULL
nucleotides	NULL
-644	NULL
(	NULL
Xho	NULL
I	NULL
)	NULL
to	NULL
+78	NULL
(	NULL
HindIII	NULL
)	NULL
of	NULL
the	NULL
HIV	NULL
LTR	NULL
(	NULL
LAV1	NULL
Bru	NULL
strain	NULL
)	NULL
,	NULL
cloned	NULL
into	NULL
the	NULL
HindIII	NULL
site	NULL
of	NULL
the	NULL
pc-luc	NULL
plasmid	NULL
,	NULL
and	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
A.	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89	NULL
(	NULL
1992	NULL
)	NULL
7827	NULL
Rabson	NULL
(	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
vector	NULL
for	NULL
the	NULL
Tax	NULL
protein	NULL
of	NULL
human	NULL
T-cell	NULL
lymphotropic	NULL
virus	NULL
type	NULL
I	NULL
was	NULL
a	NULL
gift	NULL
of	NULL
M.	NULL
Brahic	NULL
(	NULL
Institut	NULL
Pasteur	NULL
,	NULL
Paris	NULL
)	NULL
and	NULL
contained	NULL
the	NULL
Tax	NULL
cDNA	NULL
cloned	NULL
downstream	NULL
of	NULL
the	NULL
cytomegalovirus	NULL
promoter	NULL
in	NULL
the	NULL
Rc-CMV	NULL
vector	NULL
.	NULL

All	NULL
plasmids	NULL
were	NULL
purified	NULL
using	NULL
Qiagen	NULL
columns	NULL
(	NULL
Diagen	NULL
,	NULL
Dusseldorf	NULL
,	NULL
F.R.G	NULL
.	NULL
)	NULL

.	NULL

Purity	NULL
,	NULL
size	NULL
,	NULL
and	NULL
restriction	NULL
maps	NULL
were	NULL
verified	NULL
by	NULL
agarose	NULL
gel	NULL
electrophoresis	NULL
.	NULL

Transfections	NULL
.	NULL

Cells	NULL
were	NULL
seeded	NULL
at	NULL
5	NULL
x	NULL
10°	NULL
per	NULL
ml	NULL
the	NULL
same	NULL
day	NULL
as	NULL
the	NULL
routine	NULL
biweekly	NULL
cell	NULL
passage	NULL
and	NULL
were	NULL
transfected	NULL
16	NULL
hr	NULL
later	NULL
by	NULL
a	NULL
modified	NULL
DEAE-dextran	NULL
technique	NULL
(	NULL
28	NULL
,	NULL
29	NULL
)	NULL
.	NULL

In	NULL
brief	NULL
,	NULL
5	NULL
x	NULL
10°	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
2.5	NULL
ug	NULL
of	NULL
plasmid	NULL
.	NULL

In	NULL
experiments	NULL
where	NULL
two	NULL
plasmids	NULL
were	NULL
transfected	NULL
[	NULL
the	NULL
target	NULL
reporter	NULL
gene	NULL
and	NULL
the	NULL
effector	NULL
or	NULL
control	NULL
(	NULL
pc-luc	NULL
)	NULL
gene	NULL
]	NULL
,	NULL
2.5	NULL
ug	NULL
of	NULL
each	NULL
plasmid	NULL
was	NULL
used	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
suspended	NULL
in	NULL
5	NULL
ml	NULL
of	NULL
RPMI-1640/5	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
in	NULL
25-cm	NULL
flasks	NULL
,	NULL
or	NULL
further	NULL
aliquoted	NULL
into	NULL
24-well	NULL
plates	NULL
at	NULL
2	NULL
ml	NULL
per	NULL
well	NULL
,	NULL
and	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
4	NULL
hr	NULL
.	NULL

At	NULL
that	NULL
time	NULL
,	NULL
the	NULL
various	NULL
reagents	NULL
were	NULL
added	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
36	NULL
hr	NULL
later	NULL
(	NULL
29	NULL
)	NULL
and	NULL
luciferase	NULL
activity	NULL
was	NULL
measured	NULL
in	NULL
a	NULL
luminometer	NULL
(	NULL
Berthold	NULL
)	NULL
.	NULL

The	NULL
background	NULL
obtained	NULL
from	NULL
the	NULL
lysis	NULL
buffer	NULL
was	NULL
subtracted	NULL
from	NULL
each	NULL
experimental	NULL
value	NULL
.	NULL

Total	NULL
protein	NULL
in	NULL
an	NULL
aliquot	NULL
of	NULL
each	NULL
sample	NULL
was	NULL
measured	NULL
by	NULL
the	NULL
Bradford	NULL
technique	NULL
(	NULL
Bio-Rad	NULL
)	NULL
and	NULL
the	NULL
results	NULL
were	NULL
calculated	NULL
as	NULL
[	NULL
rel-ative	NULL
light	NULL
units	NULL
(	NULL
rlu	NULL
)	NULL
-	NULL
background	NULL
]	NULL
/mg	NULL
of	NULL
protein	NULL
.	NULL

Comparison	NULL
between	NULL
results	NULL
of	NULL
transfection	NULL
of	NULL
the	NULL
same	NULL
reporter	NULL
gene	NULL
into	NULL
uninfected	NULL
or	NULL
HIV-infected	NULL
cells	NULL
and	NULL
the	NULL
Hirt	NULL
technique	NULL
for	NULL
DNA	NULL
precipitation	NULL
were	NULL
done	NULL
as	NULL
described	NULL
(	NULL
20	NULL
)	NULL
.	NULL

The	NULL
basal	NULL
activity	NULL
of	NULL
p105dkB-luc	NULL
and	NULL
p105dAP1-luc	NULL
vectors	NULL
was	NULL
above	NULL
background	NULL
in	NULL
all	NULL
experiments	NULL
.	NULL

RESULTS	NULL
Activity	NULL
of	NULL
the	NULL
p105	NULL
Promoter	NULL
Is	NULL
Enhanced	NULL
in	NULL
HIV-Infected	NULL
U937	NULL
Cells	NULL
,	NULL
Through	NULL
the	NULL
NF-	NULL
«	NULL
B-Binding	NULL
Motif	NULL
of	NULL
the	NULL
Promoter	NULL
,	NULL
and	NULL
Is	NULL
Unresponsive	NULL
to	NULL
HIV	NULL
Tat	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
HIV	NULL
was	NULL
due	NULL
to	NULL
an	NULL
induction	NULL
of	NULL
p105	NULL
gene	NULL
transcription	NULL
,	NULL
we	NULL
performed	NULL
Northern	NULL
blot	NULL
analysis	NULL
and	NULL
transient	NULL
expression	NULL
assays	NULL
with	NULL
various	NULL
p105	NULL
promoter	NULL
constructs	NULL
in	NULL
uninfected	NULL
and	NULL
HIV-infected	NULL
U937	NULL
monocytes	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
demonstrated	NULL
a	NULL
2-	NULL
to	NULL
3	NULL
.	NULL

5-fold	NULL
increase	NULL
in	NULL
steady-state	NULL
levels	NULL
of	NULL
p105	NULL
mRNA	NULL
in	NULL
HIV-infected	NULL
U937	NULL
cells	NULL
as	NULL
compared	NULL
to	NULL
uninfected	NULL
cells	NULL
.	NULL

Hybridization	NULL
was	NULL
performed	NULL
in	NULL
parallel	NULL
with	NULL
glyceraldehyde-3-phosphate	NULL
de-hydrogenase	NULL
cDNA	NULL
to	NULL
control	NULL
for	NULL
RNA	NULL
quantity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

HIV	NULL
infection	NULL
resulted	NULL
in	NULL
a	NULL
4-fold	NULL
amplification	NULL
of	NULL
the	NULL
basal	NULL
activity	NULL
of	NULL
the	NULL
p105	NULL
promoter	NULL
(	NULL
p105-luc	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

As	NULL
a	NULL
positive	NULL
control	NULL
,	NULL
the	NULL
enhancer	NULL
region	NULL
of	NULL
HIV	NULL
LTR	NULL
cloned	NULL
upstream	NULL
of	NULL
the	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
(	NULL
3ENH-TKluc	NULL
)	NULL
was	NULL
used	NULL
,	NULL
resulting	NULL
in	NULL
a	NULL
similar	NULL
upregulation	NULL
in	NULL
HIV-infected	NULL
cells	NULL
,	NULL
as	NULL
described	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Induction	NULL
of	NULL
the	NULL
p105	NULL
promoter	NULL
activity	NULL
by	NULL
HIV	NULL
infection	NULL
was	NULL
dependent	NULL
on	NULL
the	NULL
NF-	NULL
«	NULL
B-binding	NULL
motif	NULL
present	NULL
in	NULL
this	NULL
promoter	NULL
,	NULL
since	NULL
deletion	NULL
of	NULL
this	NULL
sequence	NULL
from	NULL
the	NULL
transfected	NULL
p105	NULL
promoter	NULL
plasmid	NULL
(	NULL
p105dkB-luc	NULL
)	NULL
completely	NULL
abolished	NULL
induction	NULL
in	NULL
HIV-infected	NULL
cells	NULL
.	NULL

This	NULL
observation	NULL
was	NULL
confirmed	NULL
when	NULL
a	NULL
mutation	NULL
(	NULL
CTC	NULL
instead	NULL
of	NULL
GGG	NULL
)	NULL
that	NULL
specifically	NULL
abolishes	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
(	NULL
1	NULL
)	NULL
was	NULL
introduced	NULL
in	NULL
an	NULL
HIV	NULL
enhancer/thymidine	NULL
kinase	NULL
promoter	NULL
vector	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
HIV-mediated	NULL
induction	NULL
of	NULL
the	NULL
p105	NULL
promoter	NULL
was	NULL
independent	NULL
of	NULL
the	NULL
AP-1-like	NULL
motif	NULL
present	NULL
in	NULL
this	NULL
promoter	NULL
,	NULL
since	NULL
deletion	NULL
of	NULL
this	NULL
sequence	NULL
(	NULL
p105dAP1-luc	NULL
)	NULL
did	NULL
not	NULL
change	NULL
the	NULL
level	NULL
of	NULL
induction	NULL
.	NULL

Since	NULL
the	NULL
HIV-encoded	NULL
Tat	NULL
protein	NULL
is	NULL
known	NULL
to	NULL
transactivate	NULL
the	NULL
HIV	NULL
promoter	NULL
,	NULL
we	NULL
tested	NULL
whether	NULL
it	NULL
could	NULL
mediate	NULL
the	NULL
increased	NULL
activity	NULL
of	NULL
the	NULL
p10S5	NULL
promoter	NULL
in	NULL
chronically	NULL
HIV-infected	NULL
U937	NULL
cells	NULL
,	NULL
previously	NULL
reported	NULL
to	NULL
show	NULL
intense	NULL
Tat	NULL
activity	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Cotransfection	NULL
experiments	NULL
were	NULL
performed	NULL
in	NULL
uninfected	NULL
K562	NULL
cells	NULL
,	NULL
with	NULL
the	NULL
intact	NULL
p105	NULL
promoter	NULL
and	NULL
an	NULL
expression	NULL
plasmid	NULL
encoding	NULL
Tat	NULL
.	NULL

K562	NULL
cells	NULL
7828	NULL
Medical	NULL
Sciences	NULL
:	NULL
Paya	NULL
et	NULL
al	NULL
.	NULL

7000	NULL
33	NULL
I	NULL
>	NULL
o	NULL
2500	NULL
8	NULL
C-3	NULL
t	NULL
x	NULL
3	NULL
:	NULL
g	NULL
1500	NULL
©	NULL
R	NULL
£	NULL
3	NULL
A	NULL
500	NULL
0	NULL
-	NULL
H1v	NULL
0	NULL
hiv	NULL
0	NULL
-	NULL
HIV	NULL
0	NULL
_	NULL
HIV	NULL
3	NULL
ENH-TKiuc	NULL
p10§-luc	NULL
p10SdkB-fuc	NULL
p10SdAP1-luc	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Activation	NULL
of	NULL
p105	NULL
promoter	NULL
activity	NULL
by	NULL
HIV	NULL
.	NULL

Uninfected	NULL
(	NULL
0	NULL
)	NULL
or	NULL
HIV-infected	NULL
(	NULL
HIV	NULL
)	NULL
U937	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
indicated	NULL
reporter	NULL
plasmid	NULL
.	NULL

Numbers	NULL
above	NULL
the	NULL
bars	NULL
indicate	NULL
fold-stimulation	NULL
in	NULL
HIV-infected	NULL
cells	NULL
relative	NULL
to	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
same	NULL
plasmid	NULL
transfected	NULL
in	NULL
uninfected	NULL
cells	NULL
.	NULL

were	NULL
used	NULL
in	NULL
this	NULL
experiment	NULL
because	NULL
they	NULL
display	NULL
a	NULL
higher	NULL
basal	NULL
p105	NULL
promoter	NULL
activity	NULL
higher	NULL
than	NULL
U937	NULL
cells	NULL
.	NULL

Tat	NULL
was	NULL
unable	NULL
to	NULL
induce	NULL
activation	NULL
of	NULL
the	NULL
p105	NULL
promoter	NULL
,	NULL
whereas	NULL
it	NULL
was	NULL
capable	NULL
to	NULL
transactivate	NULL
the	NULL
HIV	NULL
LTR	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Similar	NULL
data	NULL
were	NULL
obtained	NULL
in	NULL
uninfected	NULL
U937	NULL
cells	NULL
.	NULL

As	NULL
a	NULL
positive	NULL
control	NULL
we	NULL
used	NULL
an	NULL
expression	NULL
plasmid	NULL
encoding	NULL
the	NULL
Tax	NULL
protein	NULL
of	NULL
human	NULL
T-cell	NULL
lymphotropic	NULL
virus	NULL
type	NULL
1	NULL
,	NULL
which	NULL
greatly	NULL
increased	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
p105	NULL
promoter	NULL
,	NULL
again	NULL
through	NULL
the	NULL
«	NULL
B	NULL
motif	NULL
.	NULL

Protein	NULL
Complex	NULL
Translocated	NULL
into	NULL
the	NULL
Nucleus	NULL
of	NULL
Chronically	NULL
Infected	NULL
U937	NULL
Cells	NULL
Is	NULL
Made	NULL
of	NULL
p50/p6S5	NULL
Heterodimers	NULL
.	NULL

Because	NULL
the	NULL
p50/p65	NULL
heterodimer	NULL
can	NULL
transactivate	NULL
the	NULL
p105	NULL
promoter	NULL
through	NULL
the	NULL
«	NULL
B	NULL
motif	NULL
(	NULL
23	NULL
)	NULL
,	NULL
we	NULL
wanted	NULL
to	NULL
determine	NULL
the	NULL
exact	NULL
molecular	NULL
composition	NULL
of	NULL
the	NULL
HIV-induced	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
.	NULL

Cells	NULL
infected	NULL
with	NULL
HIV	NULL
showed	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

Complex	NULL
formation	NULL
was	NULL
inhibited	NULL
by	NULL
competition	NULL
with	NULL
a	NULL
40-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotide	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

Preincubation	NULL
of	NULL
nuclear	NULL
extracts	NULL
with	NULL
an	NULL
antiserum	NULL
raised	NULL
against	NULL
the	NULL
p50	NULL
subunit	NULL
,	NULL
which	NULL
also	NULL
recognizes	NULL
NF-KB	NULL
(	NULL
anti-NF-	NULL
«	NULL
B	NULL
;	NULL
ref	NULL
.	NULL

5	NULL
)	NULL
,	NULL
decreased	NULL
specific	NULL
DNA-binding	NULL
activity	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
antibodies	NULL
raised	NULL
against	NULL
the	NULL
C-terminal	NULL
region	NULL
of	NULL
c-Rel	NULL
,	NULL
which	NULL
have	NULL
been	NULL
previously	NULL
shown	NULL
to	NULL
upshift	NULL
the	NULL
c-Rel	NULL
complex	NULL
(	NULL
18	NULL
)	NULL
,	NULL
did	NULL
not	NULL
modify	NULL
the	NULL
migration	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
induced	NULL
by	NULL
HIV	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

This	NULL
lack	NULL
of	NULL
effect	NULL
was	NULL
also	NULL
observed	NULL
when	NULL
preim-mune	NULL
serum	NULL
was	NULL
used	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
activity	NULL
induced	NULL
by	NULL
HIV	NULL
infection	NULL
was	NULL
blocked	NULL
when	NULL
the	NULL
nuclear	NULL
J	NULL
z	NULL
60,0003	NULL
2	NULL
)	NULL
€	NULL
16,000	NULL
3	NULL
E	NULL
x	NULL
3	NULL
12,000	NULL
4	NULL
o	NULL
f	NULL
$	NULL
8,000	NULL
3	NULL
H	NULL
4,000	NULL
0	NULL
C-	NULL
tax	NULL
tat	NULL
C-	NULL
tax	NULL
tat	NULL
C-	NULL
tax	NULL
tat	NULL
p105-lue	NULL
p1O5dKB-luc	NULL
HIV	NULL
LTR-lue	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Effect	NULL
of	NULL
Tat	NULL
on	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
p105	NULL
promoter	NULL
.	NULL

Uninfected	NULL
U937	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
indicated	NULL
reporter	NULL
plasmid	NULL
alone	NULL
(	NULL
control	NULL
,	NULL
C	NULL
)	NULL
or	NULL
cotransfected	NULL
with	NULL
the	NULL
reporter	NULL
plasmid	NULL
and	NULL
an	NULL
expression	NULL
vector	NULL
encoding	NULL
Tat	NULL
or	NULL
Tax	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89	NULL
(	NULL
1992	NULL
)	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Gel	NULL
shift	NULL
assay	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
uninfected	NULL
(	NULL
NT	NULL
)	NULL
or	NULL
HIV-infected	NULL
(	NULL
HIV	NULL
)	NULL
U937	NULL
cells	NULL
(	NULL
lanes	NULL
1-6	NULL
)	NULL
or	NULL
recombinant	NULL
p50	NULL
(	NULL
lanes	NULL
7-11	NULL
)	NULL
.	NULL

Positions	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
and	NULL
the	NULL
pSO	NULL
homodimer	NULL
are	NULL
indicated	NULL
.	NULL

Comp	NULL
.	NULL

,	NULL
competition	NULL
with	NULL
40-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotide	NULL
.	NULL

extract	NULL
was	NULL
incubated	NULL
with	NULL
recombinant	NULL
IxB	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

No	NULL
difference	NULL
in	NULL
DNA-binding	NULL
activity	NULL
was	NULL
found	NULL
when	NULL
nuclear	NULL
extracts	NULL
of	NULL
uninfected	NULL
or	NULL
HIV-infected	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
an	NULL
oligonucleotide	NULL
encompassing	NULL
the	NULL
AP-1	NULL
motif	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Purified	NULL
recombinant	NULL
p50	NULL
homodimers	NULL
were	NULL
electrophoresed	NULL
in	NULL
parallel	NULL
to	NULL
confirm	NULL
the	NULL
molecular	NULL
forms	NULL
defined	NULL
by	NULL
the	NULL
use	NULL
of	NULL
antiserum	NULL
and	NULL
IxB	NULL
(	NULL
lanes	NULL
7-11	NULL
)	NULL
.	NULL

The	NULL
recombinant	NULL
p50	NULL
is	NULL
a	NULL
truncated	NULL
form	NULL
(	NULL
amino	NULL
acids	NULL
38-381	NULL
)	NULL
and	NULL
thus	NULL
has	NULL
an	NULL
increased	NULL
electrophoretic	NULL
mobility	NULL
.	NULL

Competition	NULL
with	NULL
a	NULL
40-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotide	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
eliminated	NULL
DNA	NULL
binding	NULL
,	NULL
and	NULL
anti-p50	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
but	NULL
not	NULL
anti-c-Rel	NULL
(	NULL
lane	NULL
10	NULL
)	NULL
antiserum	NULL
upshifted	NULL
the	NULL
p50/DNA	NULL
complex	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
addition	NULL
of	NULL
recombinant	NULL
IxB	NULL
to	NULL
the	NULL
reaction	NULL
mixture	NULL
did	NULL
not	NULL
modify	NULL
the	NULL
binding	NULL
of	NULL
recombinant	NULL
p50	NULL
(	NULL
lane	NULL
11	NULL
)	NULL
.	NULL

Accumulation	NULL
of	NULL
NF-xB	NULL
in	NULL
the	NULL
Cytosol	NULL
of	NULL
HIV-1-Infected	NULL
U937	NULL
Cells	NULL
.	NULL

Gel	NULL
shift	NULL
assays	NULL
of	NULL
cytosolic	NULL
extracts	NULL
treated	NULL
with	NULL
deoxycholate	NULL
,	NULL
which	NULL
dissociates	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
from	NULL
IxB	NULL
(	NULL
13	NULL
)	NULL
,	NULL
showed	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
present	NULL
in	NULL
both	NULL
the	NULL
nuclear	NULL
and	NULL
the	NULL
cytoplasmic	NULL
compartment	NULL
of	NULL
HIV-infected	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
13	NULL
)	NULL
,	NULL
as	NULL
compared	NULL
to	NULL
uninfected	NULL
cells	NULL
in	NULL
which	NULL
NF-kB	NULL
was	NULL
only	NULL
detected	NULL
in	NULL
the	NULL
cytosol	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
7	NULL
)	NULL
.	NULL

Three-hour	NULL
PMA	NULL
stimulation	NULL
of	NULL
uninfected	NULL
cells	NULL
resulted	NULL
in	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
but	NULL
was	NULL
associated	NULL
with	NULL
a	NULL
decreased	NULL
amount	NULL
of	NULL
cytoplasmic	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
10	NULL
)	NULL
.	NULL

These	NULL
results	NULL
were	NULL
confirmed	NULL
in	NULL
four	NULL
different	NULL
experiments	NULL
using	NULL
the	NULL
same	NULL
quantity	NULL
of	NULL
cytosolic	NULL
proteins	NULL
.	NULL

These	NULL
findings	NULL
indicate	NULL
that	NULL
in	NULL
HIV-infected	NULL
U937	NULL
cells	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
increased	NULL
in	NULL
both	NULL
the	NULL
cytoplasmic	NULL
and	NULL
the	NULL
nuclear	NULL
compartment	NULL
.	NULL

Increased	NULL
Transcription	NULL
of	NULL
the	NULL
p105	NULL
Promoter	NULL
and	NULL
Nuclear	NULL
Translocation	NULL
of	NULL
NF-xB	NULL
in	NULL
HIV-Infected	NULL
Cells	NULL
Are	NULL
Not	NULL
Mediated	NULL
Through	NULL
PKC-Dependent	NULL
Cellular	NULL
Transduction	NULL
Path-ways	NULL
.	NULL

Pretreatment	NULL
with	NULL
the	NULL
highly	NULL
selective	NULL
PKC	NULL
inhibitor	NULL
GF	NULL
109203X	NULL
blocked	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
16	NULL
hr	NULL
after	NULL
PMA	NULL
stimulation	NULL
of	NULL
uninfected	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
but	NULL
did	NULL
not	NULL
block	NULL
the	NULL
translocation	NULL
induced	NULL
by	NULL
HIV	NULL
infection	NULL
during	NULL
16	NULL
hr	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
7	NULL
)	NULL
,	NULL
or	NULL
even	NULL
72	NULL
hr	NULL
.	NULL

These	NULL
observations	NULL
indicate	NULL
that	NULL
HIV	NULL
infection	NULL
induces	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
through	NULL
an	NULL
a	NULL
,	NULL
B	NULL
,	NULL
and	NULL
y	NULL
PKC	NULL
isoenzymes-independent	NULL
pathway	NULL
and	NULL
that	NULL
PMA	NULL
induces	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
through	NULL
these	NULL
PKC	NULL
isoenzymes	NULL
.	NULL

Uninfected	NULL
and	NULL
HIV-infected	NULL
cells	NULL
previously	NULL
transfected	NULL
with	NULL
the	NULL
p105	NULL
promoter	NULL
construct	NULL
were	NULL
treated	NULL
with	NULL
the	NULL
PKC	NULL
inhibitor	NULL
or	NULL
left	NULL
untreated	NULL
and	NULL
then	NULL
were	NULL
stimulated	NULL
with	NULL
PMA	NULL
or	NULL
left	NULL
unstimulated	NULL
.	NULL

PMA-induced	NULL
activation	NULL
of	NULL
the	NULL
p105	NULL
promoter	NULL
was	NULL
greatly	NULL
reduced	NULL
by	NULL
the	NULL
PKC	NULL
inhibitor	NULL
,	NULL
independently	NULL
of	NULL
HIV	NULL
infection	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

However	NULL
,	NULL
HIV	NULL
-induced	NULL
activity	NULL
of	NULL
the	NULL
p105	NULL
promoter	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
the	NULL
PKC	NULL
Medical	NULL
Sciences	NULL
:	NULL
Paya	NULL
et	NULL
al	NULL
.	NULL

NUCLEUS	NULL
CYTOSOL	NULL
HIV	NULL
=o	NULL
m	NULL
o	NULL
~	NULL
+	NULL
+	NULL
PMA	NULL
-	NULL
op	NULL
og	NULL
-	NULL
-	NULL
Pe	NULL
ies	NULL
£	NULL
Comp	NULL
.	NULL

=	NULL
-	NULL
-	NULL
g	NULL
0	NULL
-	NULL
+	NULL
Ro-	NULL
og	NULL
2	NULL
C	NULL
DOC	NULL
&	NULL
-	NULL
<	NULL
-	NULL
-	NULL
_-	NULL
wile	NULL
intone	NULL
|	NULL
gp	NULL
lige	NULL
10	NULL
2	NULL
%	NULL
3	NULL
4	NULL
S	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
FiG	NULL
.	NULL

4	NULL
.	NULL

Gel	NULL
shift	NULL
assay	NULL
with	NULL
nuclear	NULL
(	NULL
lanes	NULL
1-5	NULL
)	NULL
or	NULL
cytoplasmic	NULL
(	NULL
lanes	NULL
6-14	NULL
)	NULL
extract	NULL
of	NULL
U937	NULL
ceils	NULL
.	NULL

The	NULL
radiolabeled	NULL
oligonucleotide	NULL
and	NULL
the	NULL
competition	NULL
analysis	NULL
were	NULL
the	NULL
same	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Migration	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
is	NULL
indicated	NULL
at	NULL
left	NULL
.	NULL

DOC	NULL
,	NULL
deoxycholate	NULL
.	NULL

inhibitor	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
PMA	NULL
and	NULL
HIV	NULL
infection	NULL
on	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
p105	NULL
promoter	NULL
was	NULL
more	NULL
than	NULL
additive	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
HIV	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
,	NULL
at	NULL
the	NULL
level	NULL
of	NULL
both	NULL
p105	NULL
gene	NULL
transcription	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
nuclear	NULL
translocation	NULL
,	NULL
is	NULL
achieved	NULL
through	NULL
cellular	NULL
transduction	NULL
pathway	NULL
(	NULL
s	NULL
)	NULL
different	NULL
from	NULL
that	NULL
used	NULL
by	NULL
PMA	NULL
.	NULL

DISCUSSION	NULL
Study	NULL
of	NULL
the	NULL
mechanism	NULL
(	NULL
s	NULL
)	NULL
by	NULL
which	NULL
HIV	NULL
infection	NULL
activates	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
the	NULL
monocytic	NULL
cell	NULL
line	NULL
U937	NULL
may	NULL
help	NULL
us	NULL
to	NULL
understand	NULL
the	NULL
chronic	NULL
infection	NULL
with	NULL
persistent	NULL
viral	NULL
replication	NULL
observed	NULL
in	NULL
human	NULL
brain	NULL
macrophages	NULL
of	NULL
HIV-infected	NULL
patients	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Molecular	NULL
analysis	NULL
of	NULL
this	NULL
model	NULL
shows	NULL
that	NULL
HIV	NULL
infection	NULL
induces	NULL
nuclear	NULL
DNA-binding	NULL
activity	NULL
of	NULL
p50/p65	NULL
heterodimers	NULL
.	NULL

The	NULL
c-Rel	NULL
protein	NULL
is	NULL
known	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
p50	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
to	NULL
have	NULL
DNA-binding	NULL
activity	NULL
(	NULL
18	NULL
,	NULL
31	NULL
)	NULL
.	NULL

However	NULL
,	NULL
we	NULL
could	NULL
not	NULL
detect	NULL
c-Rel	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
infected	NULL
U937	NULL
cells	NULL
.	NULL

Antibodies	NULL
to	NULL
c-rel	NULL
did	NULL
not	NULL
react	NULL
with	NULL
any	NULL
of	NULL
the	NULL
induced	NULL
complexes	NULL
,	NULL
whereas	NULL
antibodies	NULL
to	NULL
pS0	NULL
did	NULL
.	NULL

Addition	NULL
of	NULL
recombinant	NULL
IxB	NULL
eliminated	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
induced	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
but	NULL
not	NULL
that	NULL
of	NULL
recombinant	NULL
p50	NULL
homodimers	NULL
.	NULL

IxB	NULL
a	NULL
does	NULL
not	NULL
inhibit	NULL
DNA	NULL
binding	NULL
of	NULL
c-Rel	NULL
(	NULL
26	NULL
,	NULL
32	NULL
,	NULL
33	NULL
)	NULL
.	NULL

Therecombinant	NULL
human	NULL
IxB	NULL
that	NULL
we	NULL
have	NULL
used	NULL
is	NULL
derived	NULL
from	NULL
the	NULL
MAD-3	NULL
sequence	NULL
(	NULL
26	NULL
)	NULL
,	NULL
which	NULL
is	NULL
similar	NULL
to	NULL
I	NULL
«	NULL
B	NULL
a	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
molecular	NULL
form	NULL
of	NULL
the	NULL
HIV	NULL
-	NULL
nell	NULL
es	NULL
C	NULL
pO	NULL
$	NULL
o	NULL
4	NULL
PMA	NULL
-	NULL
o	NULL
$	NULL
+	NULL
+	NULL
&	NULL
Comp	NULL
.	NULL

=o	NULL
oso	NULL
go-	NULL
¥	NULL
.	NULL

--	NULL
PKC	NULL
inhib	NULL
.	NULL

_	NULL
-	NULL
=-	NULL
-	NULL
+0	NULL
-o	NULL
-	NULL
4	NULL
NF-kB	NULL
--	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Gel	NULL
shift	NULL
assay	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
uninfected	NULL
(	NULL
lanes	NULL
1-4	NULL
)	NULL
or	NULL
HIV-infected	NULL
(	NULL
lanes	NULL
5-7	NULL
)	NULL
U937	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
treated	NULL
with	NULL
2.5	NULL
mM	NULL
PKC	NULL
inhibitor	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
7	NULL
)	NULL
or	NULL
left	NULL
untreated	NULL
(	NULL
lanes	NULL
1-3	NULL
,	NULL
5	NULL
,	NULL
and	NULL
6	NULL
)	NULL
.	NULL

PMA	NULL
(	NULL
20	NULL
ng/ml	NULL
)	NULL
was	NULL
added	NULL
30	NULL
min	NULL
later	NULL
(	NULL
lanes	NULL
2-4	NULL
)	NULL
.	NULL

Comp	NULL
.	NULL

,	NULL
competition	NULL
with	NULL
a	NULL
40-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotide	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89	NULL
(	NULL
1992	NULL
)	NULL
7829	NULL
PMA	NULL
GF	NULL
uo37	NULL
-	NULL
j	NULL
He	NULL
4.8	NULL
vosr|	NULL
=	NULL
_	NULL
*	NULL
5.0	NULL
HIv	NULL
|	NULL
400	NULL
L	NULL
|	NULL
BE	NULL
+	NULL
i	NULL
--	NULL
500	NULL
1500	NULL
2500	NULL
_	NULL
9000	NULL
Luciferase	NULL
index	NULL
,	NULL
rlu/mg	NULL
FiG	NULL
.	NULL

6	NULL
.	NULL

Effect	NULL
of	NULL
PKC	NULL
inhibitor	NULL
(	NULL
GF	NULL
)	NULL
on	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
p105	NULL
promoter	NULL
by	NULL
PMA	NULL
and	NULL
HIV	NULL
.	NULL

Uninfected	NULL
or	NULL
HIV-infected	NULL
U937	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
p105-luc	NULL
construct	NULL
.	NULL

Numbers	NULL
to	NULL
the	NULL
right	NULL
of	NULL
the	NULL
bars	NULL
indicate	NULL
fold-stimulation	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
promoter	NULL
activity	NULL
obtained	NULL
in	NULL
uninfected	NULL
,	NULL
untreated	NULL
cells	NULL
.	NULL

Concentrations	NULL
of	NULL
PMA	NULL
and	NULL
PKC	NULL
inhibitor	NULL
are	NULL
the	NULL
same	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

5.	NULL
protein	NULL
translocated	NULL
into	NULL
the	NULL
nuclei	NULL
of	NULL
U937	NULL
cells	NULL
during	NULL
chronic	NULL
HIV	NULL
infection	NULL
is	NULL
a	NULL
heterodimeric	NULL
complex	NULL
containing	NULL
p65	NULL
but	NULL
not	NULL
c-Rel	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
was	NULL
found	NULL
consistently	NULL
to	NULL
be	NULL
increased	NULL
in	NULL
cytosolic	NULL
extracts	NULL
from	NULL
HIV-infected	NULL
cells	NULL
as	NULL
compared	NULL
with	NULL
extracts	NULL
of	NULL
control	NULL
cells	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
NF-	NULL
B	NULL
could	NULL
even	NULL
be	NULL
detected	NULL
in	NULL
infected	NULL
,	NULL
but	NULL
not	NULL
control	NULL
,	NULL
cells	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
deoxycholate	NULL
treatment	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
contrast	NULL
with	NULL
results	NULL
obtained	NULL
following	NULL
PMA	NULL
stimulation	NULL
of	NULL
control	NULL
U937	NULL
cells	NULL
,	NULL
where	NULL
a	NULL
decrease	NULL
in	NULL
cytosolic	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
a	NULL
parallel	NULL
increase	NULL
of	NULL
the	NULL
complex	NULL
in	NULL
the	NULL
nucleus	NULL
were	NULL
seen	NULL
,	NULL
as	NULL
previously	NULL
reported	NULL
(	NULL
32	NULL
)	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
HIV	NULL
infection	NULL
of	NULL
U937	NULL
cells	NULL
continuously	NULL
induces	NULL
formation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
,	NULL
resulting	NULL
in	NULL
its	NULL
accumulation	NULL
in	NULL
both	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
compartments	NULL
.	NULL

As	NULL
shown	NULL
by	NULL
transient	NULL
transfection	NULL
experiments	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
p10S5	NULL
promoter	NULL
was	NULL
increased	NULL
in	NULL
chronically	NULL
infected	NULL
cells	NULL
.	NULL

This	NULL
enhancement	NULL
was	NULL
dependent	NULL
on	NULL
the	NULL
«	NULL
B	NULL
,	NULL
but	NULL
not	NULL
the	NULL
AP-1	NULL
,	NULL
motif	NULL
of	NULL
the	NULL
promoter	NULL
.	NULL

This	NULL
indicated	NULL
that	NULL
the	NULL
xB	NULL
motif	NULL
was	NULL
necessary	NULL
for	NULL
p105	NULL
promoter	NULL
induction	NULL
by	NULL
HIV	NULL
,	NULL
supporting	NULL
the	NULL
concept	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
autoregulatory	NULL
mechanisms	NULL
are	NULL
used	NULL
by	NULL
HIV	NULL
to	NULL
induce	NULL
and	NULL
perpetuate	NULL
NF-	NULL
«	NULL
B	NULL
functions	NULL
in	NULL
chronically	NULL
infected	NULL
monocytes	NULL
.	NULL

Phosphorylation	NULL
of	NULL
Ix	NULL
B	NULL
through	NULL
the	NULL
activation	NULL
of	NULL
PKC	NULL
,	NULL
as	NULL
seen	NULL
following	NULL
PMA	NULL
stimulation	NULL
,	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
responsible	NULL
for	NULL
translocation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
to	NULL
the	NULL
nucleus	NULL
(	NULL
9	NULL
,	NULL
12	NULL
,	NULL
13	NULL
,	NULL
26	NULL
)	NULL
.	NULL

Our	NULL
data	NULL
show	NULL
that	NULL
HIV	NULL
infection	NULL
does	NULL
not	NULL
use	NULL
the	NULL
a	NULL
,	NULL
B	NULL
,	NULL
or	NULL
y	NULL
PKC	NULL
pathway	NULL
utilized	NULL
by	NULL
PMA	NULL
to	NULL
increase	NULL
NF-	NULL
«	NULL
B	NULL
nuclear	NULL
translocation	NULL
.	NULL

Using	NULL
a	NULL
highly	NULL
specific	NULL
inhibitor	NULL
of	NULL
these	NULL
PKC	NULL
isoenzymes	NULL
(	NULL
24	NULL
,	NULL
28	NULL
)	NULL
,	NULL
we	NULL
have	NULL
found	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
translocation	NULL
and	NULL
subsequent	NULL
stimulation	NULL
of	NULL
the	NULL
p105	NULL
promoter	NULL
by	NULL
PMA	NULL
are	NULL
dependent	NULL
on	NULL
PKC	NULL
isotypes	NULL
,	NULL
since	NULL
these	NULL
processes	NULL
were	NULL
abolished	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
this	NULL
inhibitor	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
induced	NULL
by	NULL
HIV	NULL
infection	NULL
was	NULL
not	NULL
blocked	NULL
but	NULL
was	NULL
,	NULL
if	NULL
anything	NULL
,	NULL
somewhat	NULL
increased	NULL
by	NULL
incubation	NULL
of	NULL
infected	NULL
cells	NULL
with	NULL
this	NULL
specific	NULL
inhibitor	NULL
.	NULL

Further	NULL
,	NULL
the	NULL
synergistic	NULL
effect	NULL
of	NULL
PMA	NULL
and	NULL
HIV	NULL
infection	NULL
on	NULL
the	NULL
enhancement	NULL
of	NULL
p105	NULL
gene	NULL
transcription	NULL
indicates	NULL
that	NULL
these	NULL
two	NULL
stimuli	NULL
use	NULL
different	NULL
,	NULL
complementary	NULL
transduction	NULL
path-ways	NULL
.	NULL

PKC-independent	NULL
intracellular	NULL
transduction	NULL
pathways	NULL
leading	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
translocation	NULL
have	NULL
been	NULL
described	NULL
(	NULL
14	NULL
,	NULL
35-37	NULL
)	NULL
.	NULL

TNF	NULL
upregulates	NULL
two	NULL
PKC-independent	NULL
pathways	NULL
,	NULL
those	NULL
dependent	NULL
on	NULL
phospholipase	NULL
A	NULL
;	NULL
hydrolysis	NULL
and	NULL
phos-phatidylcholine-specific	NULL
phospholipase	NULL
C	NULL
activity	NULL
(	NULL
38	NULL
,	NULL
39	NULL
)	NULL
.	NULL

Chronic	NULL
HIV	NULL
infection	NULL
in	NULL
U937	NULL
cells	NULL
does	NULL
not	NULL
induce	NULL
TNF	NULL
or	NULL
interleukin	NULL
1	NULL
(	NULL
ref	NULL
.	NULL

20	NULL
;	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
;	NULL
however	NULL
,	NULL
we	NULL
can	NULL
not	NULL
7830	NULL
-	NULL
Medical	NULL
Sciences	NULL
:	NULL
Paya	NULL
et	NULL
al	NULL
.	NULL

formally	NULL
exclude	NULL
that	NULL
TNF	NULL
is	NULL
produced	NULL
,	NULL
but	NULL
not	NULL
exported	NULL
,	NULL
and	NULL
thus	NULL
acting	NULL
endogenously	NULL
.	NULL

Nevertheless	NULL
,	NULL
other	NULL
authors	NULL
have	NULL
shown	NULL
that	NULL
chronic	NULL
HIV	NULL
infection	NULL
of	NULL
monocytic	NULL
cells	NULL
does	NULL
not	NULL
increase	NULL
TNF	NULL
or	NULL
interleukin	NULL
1	NULL
mRNA	NULL
(	NULL
40	NULL
)	NULL
,	NULL
making	NULL
it	NULL
unlikely	NULL
that	NULL
HIV	NULL
acts	NULL
through	NULL
these	NULL
cytokines	NULL
.	NULL

Another	NULL
possible	NULL
mechanism	NULL
independent	NULL
from	NULL
HIV	NULL
regulation	NULL
of	NULL
cellular	NULL
transduction	NULL
pathways	NULL
would	NULL
be	NULL
that	NULL
viral	NULL
products	NULL
themselves	NULL
lead	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
translocation	NULL
.	NULL

The	NULL
HIV	NULL
protease	NULL
in	NULL
vitro	NULL
can	NULL
process	NULL
the	NULL
p105	NULL
precursor	NULL
to	NULL
give	NULL
rise	NULL
to	NULL
a	NULL
p5Q-like	NULL
molecule	NULL
(	NULL
5	NULL
,	NULL
41	NULL
)	NULL
.	NULL

However	NULL
,	NULL
we	NULL
have	NULL
been	NULL
unable	NULL
to	NULL
find	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
two	NULL
lymphoblastoid	NULL
T-cell	NULL
lines	NULL
(	NULL
CEM	NULL
and	NULL
J.Jhan	NULL
)	NULL
chronically	NULL
infected	NULL
with	NULL
the	NULL
LAV-1	NULL
Bru	NULL
strain	NULL
of	NULL
HIV	NULL
under	NULL
conditions	NULL
strictly	NULL
comparable	NULL
to	NULL
those	NULL
used	NULL
in	NULL
the	NULL
present	NULL
work	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
argues	NULL
against	NULL
a	NULL
direct	NULL
role	NULL
for	NULL
HIV	NULL
proteins	NULL
,	NULL
presumably	NULL
produced	NULL
equally	NULL
well	NULL
in	NULL
infected	NULL
T	NULL
cells	NULL
and	NULL
monocytes	NULL
,	NULL
in	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
observed	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

Chronic	NULL
HIV	NULL
infection	NULL
of	NULL
monocytic	NULL
cells	NULL
continuously	NULL
increases	NULL
HIV	NULL
transcription	NULL
itself	NULL
,	NULL
in	NULL
a	NULL
loop	NULL
of	NULL
amplification	NULL
that	NULL
may	NULL
participate	NULL
in	NULL
the	NULL
perpetuation	NULL
of	NULL
infection	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
myelomonocytic	NULL
lineage	NULL
(	NULL
20	NULL
)	NULL
.	NULL

We	NULL
now	NULL
show	NULL
that	NULL
such	NULL
a	NULL
loop	NULL
may	NULL
be	NULL
further	NULL
amplified	NULL
by	NULL
increased	NULL
synthesis	NULL
of	NULL
p105	NULL
protein	NULL
as	NULL
a	NULL
result	NULL
of	NULL
the	NULL
continuous	NULL
HIV-induced	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

The	NULL
p105	NULL
precursor	NULL
is	NULL
evenly	NULL
distributed	NULL
in	NULL
the	NULL
cytosol	NULL
,	NULL
has	NULL
no	NULL
DNA-binding	NULL
activity	NULL
,	NULL
and	NULL
is	NULL
processed	NULL
into	NULL
an	NULL
active	NULL
N-terminal	NULL
p50	NULL
subunit	NULL
(	NULL
5	NULL
,	NULL
42	NULL
)	NULL
.	NULL

Accumulated	NULL
p50	NULL
in	NULL
the	NULL
cytosol	NULL
is	NULL
likely	NULL
to	NULL
form	NULL
a	NULL
complex	NULL
with	NULL
p65	NULL
.	NULL

Preliminary	NULL
data	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
indicate	NULL
that	NULL
p65	NULL
gene	NULL
transcription	NULL
is	NULL
constitutively	NULL
high	NULL
in	NULL
U937	NULL
cells	NULL
and	NULL
is	NULL
not	NULL
modulated	NULL
by	NULL
PMA	NULL
(	NULL
in	NULL
contrast	NULL
to	NULL
p105	NULL
gene	NULL
transcription	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
production	NULL
of	NULL
p6S	NULL
is	NULL
not	NULL
a	NULL
limiting	NULL
factor	NULL
in	NULL
the	NULL
accumulation	NULL
of	NULL
p50/p65	NULL
heterodimers	NULL
observed	NULL
in	NULL
chronically	NULL
infected	NULL
U937	NULL
cells	NULL
.	NULL

Therefore	NULL
,	NULL
upregulation	NULL
of	NULL
p105	NULL
gene	NULL
transcription	NULL
may	NULL
be	NULL
critical	NULL
for	NULL
replenishment	NULL
of	NULL
p50/p65	NULL
heterodimers	NULL
in	NULL
the	NULL
cytoplasmic	NULL
compartment	NULL
,	NULL
avoiding	NULL
the	NULL
exhaustion	NULL
of	NULL
the	NULL
cytoplasmic	NULL
pool	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
that	NULL
would	NULL
be	NULL
expected	NULL
as	NULL
a	NULL
consequence	NULL
of	NULL
continuous	NULL
translocation	NULL
from	NULL
the	NULL
cytoplasm	NULL
to	NULL
the	NULL
nucleus	NULL
of	NULL
chronically	NULL
infected	NULL
cells	NULL
and	NULL
thus	NULL
permitting	NULL
the	NULL
sustained	NULL
levels	NULL
of	NULL
HIV	NULL
transcription	NULL
observed	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
monocytic	NULL
lineage	NULL
chronically	NULL
infected	NULL
with	NULL
HIV	NULL
.	NULL

We	NULL
are	NULL
grateful	NULL
to	NULL
I.	NULL
Verma	NULL
for	NULL
c-Rel	NULL
antiserum	NULL
,	NULL
to	NULL
A.	NULL
Israel	NULL
for	NULL
p50	NULL
antiserum	NULL
and	NULL
helpful	NULL
discussion	NULL
of	NULL
the	NULL
manuscript	NULL
,	NULL
to	NULL
F.	NULL
Arenzana-Seisdedos	NULL
for	NULL
encouragement	NULL
and	NULL
discussions	NULL
,	NULL
to	NULL
S.	NULL
Michelson	NULL
for	NULL
useful	NULL
discussion	NULL
and	NULL
review	NULL
of	NULL
the	NULL
manuscript	NULL
,	NULL
and	NULL
to	NULL
M.	NULL
Paya	NULL
and	NULL
V.	NULL
del	NULL
Rocio	NULL
for	NULL
continuous	NULL
encouragement	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
Association	NULL
National	NULL
pour	NULL
la	NULL
Recherche	NULL
du	NULL
SIDA	NULL
and	NULL
Ligue	NULL
Nationale	NULL
contre	NULL
le	NULL
Cancer	NULL
.	NULL

C.	NULL
V.P	NULL
.	NULL

was	NULL
supported	NULL
by	NULL
a	NULL
Mayo	NULL
Foundation	NULL
scholarship	NULL
and	NULL
a	NULL
fellowship	NULL
from	NULL
the	NULL
European	NULL
Economic	NULL
Community	NULL
.	NULL

R.T.H	NULL
.	NULL

was	NULL
supported	NULL
by	NULL
the	NULL
Medical	NULL
Research	NULL
Council	NULL
AIDS	NULL
Directed	NULL
Programme	NULL
.	NULL

1	NULL
.	NULL

Nabel	NULL
,	NULL
G.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1987	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
326	NULL
,	NULL
711-713	NULL
.	NULL

2	NULL
.	NULL

Kawakami	NULL
,	NULL
H.	NULL
,	NULL
Scheidereit	NULL
,	NULL
C.	NULL
&	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85	NULL
,	NULL
4700-4704	NULL
.	NULL

3	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

3	NULL
,	NULL
1689-1698	NULL
.	NULL

4	NULL
.	NULL

Urban	NULL
,	NULL
M.	NULL
B	NULL
.	NULL

&	NULL
Bacuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

4	NULL
,	NULL
1975-1984	NULL
.	NULL

5	NULL
.	NULL

Kieran	NULL
,	NULL
M.	NULL
,	NULL
Blank	NULL
,	NULL
V.	NULL
,	NULL
Logeat	NULL
,	NULL
F.	NULL
,	NULL
Vandekerckhove	NULL
,	NULL
J.	NULL
,	NULL
Lottspeich	NULL
,	NULL
F.	NULL
,	NULL
Le	NULL
Bail	NULL
,	NULL
O.	NULL
,	NULL
Urban	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Kourilsky	NULL
,	NULL
P.	NULL
,	NULL
Bacuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

&	NULL
Israel	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
62	NULL
,	NULL
1007-1018	NULL
.	NULL

Ghosh	NULL
,	NULL
S.	NULL
,	NULL
Gifford	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Riviere	NULL
,	NULL
L.	NULL
R.	NULL
,	NULL
Tempst	NULL
,	NULL
P.	NULL
,	NULL
Nolan	NULL
,	NULL
G.	NULL
P.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
62	NULL
,	NULL
1019-1029	NULL
.	NULL

Bours	NULL
,	NULL
V.	NULL
,	NULL
Villalobos	NULL
,	NULL
J.	NULL
,	NULL
Burd	NULL
,	NULL
P.	NULL
R.	NULL
,	NULL
Kelly	NULL
,	NULL
K.	NULL
&	NULL
Siebenlist	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
348	NULL
,	NULL
76-80	NULL
.	NULL

Nolan	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
Ghosh	NULL
,	NULL
S.	NULL
,	NULL
Lion	NULL
,	NULL
H.-C.	NULL
,	NULL
Tempst	NULL
,	NULL
P.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
64	NULL
,	NULL
961-969	NULL
.	NULL

Ruben	NULL
,	NULL
S.	NULL
,	NULL
Dillon	NULL
,	NULL
P.	NULL
,	NULL
Schereck	NULL
,	NULL
R.	NULL
,	NULL
Henkel	NULL
,	NULL
T.	NULL
,	NULL
Chen	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
Maher	NULL
,	NULL
M.	NULL
,	NULL
Bacuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

&	NULL
Rosen	NULL
,	NULL
C.	NULL
(	NULL
1991	NULL
)	NULL
Science	NULL
251	NULL
,	NULL
1490-1493	NULL
.	NULL

0	NULL
-	NULL
®	NULL
on	NULL
_	NULL
a	NULL
10	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89	NULL
(	NULL
1992	NULL
)	NULL
Bacuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
53	NULL
,	NULL
211-217	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Science	NULL
242	NULL
,	NULL
540-546	NULL
.	NULL

Zabel	NULL
,	NULL
U	NULL
.	NULL

&	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
61	NULL
,	NULL
255-265	NULL
.	NULL

Ghosh	NULL
,	NULL
S.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
344	NULL
,	NULL
678-682	NULL
.	NULL

Shirakawa	NULL
,	NULL
F.	NULL
,	NULL
Chedid	NULL
,	NULL
M.	NULL
,	NULL
Suttler	NULL
,	NULL
J.	NULL
,	NULL
Pollok	NULL
,	NULL
B	NULL
.	NULL

A	NULL
.	NULL

&	NULL
Mizel	NULL
,	NULL
S.	NULL
B	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
,	NULL
959-964	NULL
.	NULL

Urban	NULL
,	NULL
M.	NULL
B	NULL
.	NULL

&	NULL
Baecuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
New	NULL
Biol	NULL
.	NULL

3	NULL
,	NULL
279-288	NULL
.	NULL

Zabel	NULL
,	NULL
U.	NULL
,	NULL
Schreck	NULL
,	NULL
R.	NULL
&	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
252-260	NULL
.	NULL

Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Walker	NULL
,	NULL
W.	NULL
H.	NULL
,	NULL
Doerre	NULL
,	NULL
S.	NULL
,	NULL
Sista	NULL
,	NULL
P.	NULL
,	NULL
Molitor	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Dixon	NULL
,	NULL
E.	NULL
P.	NULL
,	NULL
Peffer	NULL
,	NULL
N.	NULL
J.	NULL
,	NULL
Hanninck	NULL
,	NULL
M.	NULL
&	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
63	NULL
,	NULL
803-814	NULL
.	NULL

Inoue	NULL
,	NULL
J.	NULL
I.	NULL
,	NULL
Kerr	NULL
,	NULL
L.	NULL
D.	NULL
,	NULL
Ransone	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
Bengal	NULL
,	NULL
E.	NULL
,	NULL
Hunter	NULL
,	NULL
T.	NULL
&	NULL
Verma	NULL
,	NULL
I.	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
,	NULL
3715-3719	NULL
.	NULL

Urban	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Schreck	NULL
,	NULL
R.	NULL
&	NULL
Bacuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

10	NULL
,	NULL
1817-1825	NULL
.	NULL

Bachelerie	NULL
,	NULL
F.	NULL
,	NULL
Alcami	NULL
,	NULL
J.	NULL
,	NULL
Arenzana-Seisdedos	NULL
,	NULL
F.	NULL
&	NULL
Virelizier	NULL
,	NULL
J.-L.	NULL
(	NULL
1991	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
350	NULL
,	NULL
709-712	NULL
.	NULL

Hohmann	NULL
,	NULL
H.-P.	NULL
,	NULL
Remy	NULL
,	NULL
R.	NULL
,	NULL
Scheidereit	NULL
,	NULL
C.	NULL
&	NULL
van	NULL
Loon	NULL
,	NULL
A.	NULL
P.	NULL
G.	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

11	NULL
,	NULL
259-266	NULL
.	NULL

Meyer	NULL
,	NULL
R.	NULL
,	NULL
Hatada	NULL
,	NULL
E.	NULL
N.	NULL
,	NULL
Hohmann	NULL
,	NULL
H.	NULL
P.	NULL
,	NULL
Haiker	NULL
,	NULL
M.	NULL
,	NULL
Bartsch	NULL
,	NULL
C.	NULL
,	NULL
Rothlisberger	NULL
,	NULL
U.	NULL
,	NULL
Lahm	NULL
,	NULL
H.	NULL
W.	NULL
,	NULL
Schlaeger	NULL
,	NULL
E.	NULL
J.	NULL
,	NULL
van	NULL
Loon	NULL
,	NULL
A.	NULL
P.	NULL
G.	NULL
M.	NULL
&	NULL
Scheidereit	NULL
,	NULL
C.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
,	NULL
966-970	NULL
.	NULL

Ten	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Paya	NULL
,	NULL
C.	NULL
V.	NULL
,	NULL
Israel	NULL
,	NULL
N.	NULL
,	NULL
Le	NULL
Bail	NULL
,	NULL
O.	NULL
,	NULL
Mattei	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
Virelizier	NULL
,	NULL
J.-L.	NULL
,	NULL
Kourilsky	NULL
,	NULL
P.	NULL
&	NULL
Israel	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

11	NULL
,	NULL
195-203	NULL
.	NULL

Toullec	NULL
,	NULL
D.	NULL
,	NULL
Pianetti	NULL
,	NULL
P.	NULL
,	NULL
Coste	NULL
,	NULL
H.	NULL
,	NULL
Bellevergue	NULL
,	NULL
P.	NULL
,	NULL
Grand-Perret	NULL
,	NULL
T.	NULL
,	NULL
Ajakane	NULL
,	NULL
M.	NULL
,	NULL
Baudet	NULL
,	NULL
V.	NULL
,	NULL
Boissin	NULL
,	NULL
P.	NULL
,	NULL
Boursier	NULL
,	NULL
E.	NULL
,	NULL
Loriolle	NULL
,	NULL
F.	NULL
,	NULL
Duhamel	NULL
,	NULL
L.	NULL
,	NULL
Charon	NULL
,	NULL
D.	NULL
&	NULL
Kirilovsky	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
15771-15781	NULL
.	NULL

Smith	NULL
,	NULL
D.	NULL
B	NULL
.	NULL

&	NULL
Johnson	NULL
,	NULL
K.	NULL
S.	NULL
(	NULL
1988	NULL
)	NULL
Gene	NULL
67	NULL
,	NULL
31-40	NULL
.	NULL

Haskill	NULL
,	NULL
S.	NULL
,	NULL
Berg	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Thompkins	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Morris	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Yurochko	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
Sampson-Johannes	NULL
,	NULL
A.	NULL
,	NULL
Mondal	NULL
,	NULL
K.	NULL
,	NULL
Ralph	NULL
,	NULL
P.	NULL
&	NULL
Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
65	NULL
,	NULL
1281-1289.	NULL
deWet	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Wood	NULL
,	NULL
K.	NULL
V.	NULL
,	NULL
deLuca	NULL
,	NULL
M.	NULL
,	NULL
Helsinki	NULL
,	NULL
D.	NULL
&	NULL
Subramani	NULL
,	NULL
S.	NULL
(	NULL
1987	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7	NULL
,	NULL
725-737	NULL
.	NULL

Schwartz	NULL
,	NULL
O.	NULL
,	NULL
Virelizier	NULL
,	NULL
J.-L.	NULL
,	NULL
Montagnier	NULL
,	NULL
L.	NULL
&	NULL
Hazan	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Gene	NULL
88	NULL
,	NULL
197-205	NULL
.	NULL

Paya	NULL
,	NULL
C.	NULL
V.	NULL
,	NULL
Virelizier	NULL
,	NULL
J.-L.	NULL
&	NULL
Michelson	NULL
,	NULL
S.	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

65	NULL
,	NULL
5477-5844	NULL
.	NULL

Koenig	NULL
,	NULL
S.	NULL
,	NULL
Gendelman	NULL
,	NULL
H.	NULL
E.	NULL
,	NULL
Orenstein	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Del	NULL
Canto	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Pezeshkpour	NULL
,	NULL
G.	NULL
H.	NULL
,	NULL
Yungblut	NULL
,	NULL
M.	NULL
,	NULL
Janotta	NULL
,	NULL
F.	NULL
,	NULL
Ak-samit	NULL
,	NULL
A.	NULL
,	NULL
Martin	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

&	NULL
Fauci	NULL
,	NULL
A.	NULL
S.	NULL
(	NULL
1986	NULL
)	NULL
Science	NULL
233	NULL
,	NULL
1089-1093	NULL
.	NULL

Molitor	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Walker	NULL
,	NULL
W.	NULL
H.	NULL
,	NULL
Doerre	NULL
,	NULL
S.	NULL
,	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
&	NULL
Green	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87	NULL
,	NULL
10028-10032	NULL
.	NULL

Kerr	NULL
,	NULL
L.	NULL
D.	NULL
,	NULL
Inoue	NULL
,	NULL
J	NULL
.	NULL

-I.	NULL
,	NULL
Davis	NULL
,	NULL
N.	NULL
,	NULL
Link	NULL
,	NULL
E.	NULL
,	NULL
Bacuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Bose	NULL
,	NULL
H.	NULL
R.	NULL
&	NULL
Verma	NULL
,	NULL
I.	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

5	NULL
,	NULL
1464-1476	NULL
.	NULL

Davis	NULL
,	NULL
N.	NULL
,	NULL
Ghosh	NULL
,	NULL
S.	NULL
,	NULL
Simmons	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Tempst	NULL
,	NULL
P.	NULL
,	NULL
Liou	NULL
,	NULL
H.	NULL
C.	NULL
,	NULL
Baltimore	NULL
,	NULL
D.	NULL
&	NULL
Bose	NULL
,	NULL
H.	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Science	NULL
253	NULL
,	NULL
1268-1271	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
in	NULL
Control	NULL
of	NULL
Human	NULL
Retrovirus	NULL
Gene	NULL
Expression	NULL
,	NULL
eds	NULL
.	NULL

Franza	NULL
,	NULL
B.	NULL
R.	NULL
,	NULL
Cullen	NULL
,	NULL
B.	NULL
R.	NULL
&	NULL
Wong-Staal	NULL
,	NULL
F.	NULL
(	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Lab	NULL
.	NULL

,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
)	NULL
,	NULL
pp	NULL
.	NULL

217-226	NULL
.	NULL

Thevenin	NULL
,	NULL
C.	NULL
,	NULL
Kim	NULL
,	NULL
S.-J	NULL
.	NULL

,	NULL
Rieckmann	NULL
,	NULL
P.	NULL
,	NULL
Fujiki	NULL
,	NULL
H.	NULL
,	NULL
Norcross	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Sporn	NULL
,	NULL
M..	NULL
B.	NULL
,	NULL
Fauci	NULL
,	NULL
A.	NULL
S.	NULL
&	NULL
Kehrl	NULL
,	NULL
J.	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
New	NULL
Biol	NULL
.	NULL

2	NULL
,	NULL
793-800	NULL
.	NULL

Meichle	NULL
,	NULL
A.	NULL
,	NULL
Schutze	NULL
,	NULL
S.	NULL
,	NULL
Hensel	NULL
,	NULL
G.	NULL
,	NULL
Brunsing	NULL
,	NULL
D.	NULL
&	NULL
Kronke	NULL
,	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265	NULL
,	NULL
8339-8343	NULL
.	NULL

Feuillard	NULL
,	NULL
J.	NULL
,	NULL
Gouy	NULL
,	NULL
H.	NULL
,	NULL
Bismuth	NULL
,	NULL
G.	NULL
,	NULL
Lee	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Debre	NULL
,	NULL
P.	NULL
&	NULL
Korner	NULL
,	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
Cytokine	NULL
3	NULL
,	NULL
257-265	NULL
.	NULL

Haliday	NULL
,	NULL
E.	NULL
M.	NULL
,	NULL
Ramesha	NULL
,	NULL
C.	NULL
S.	NULL
&	NULL
Ringold	NULL
,	NULL
G.	NULL
(	NULL
1991	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

10	NULL
,	NULL
109-115	NULL
.	NULL

Schutze	NULL
,	NULL
S.	NULL
,	NULL
Berkovic	NULL
,	NULL
D.	NULL
,	NULL
Tomsing	NULL
,	NULL
O.	NULL
,	NULL
Unger	NULL
,	NULL
C.	NULL
&	NULL
Kronke	NULL
,	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

VH	NULL
,	NULL
915-988	NULL
.	NULL

Molina	NULL
,	NULL
J.-M.	NULL
,	NULL
Scadden	NULL
,	NULL
D.	NULL
T.	NULL
,	NULL
Amirault	NULL
,	NULL
C.	NULL
,	NULL
Woon	NULL
,	NULL
A.	NULL
,	NULL
Van-nier	NULL
,	NULL
E.	NULL
,	NULL
Dinarello	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

&	NULL
Groapman	NULL
,	NULL
J.	NULL
E.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

64	NULL
,	NULL
2901-2906	NULL
.	NULL

Riviere	NULL
,	NULL
Y.	NULL
,	NULL
Blank	NULL
,	NULL
V.	NULL
,	NULL
Kourilsky	NULL
,	NULL
P.	NULL
&	NULL
Israel	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
350	NULL
,	NULL
625-626	NULL
.	NULL

Fan	NULL
,	NULL
C.-M.	NULL
&	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1991	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
354	NULL
,	NULL
395-398	NULL
.	NULL

